Jaguar Health Inc (JAGX)
1.20
+0.04
(+3.00%)
USD |
NASDAQ |
Sep 27, 16:00
1.18
-0.02
(-1.67%)
After-Hours: 20:00
Jaguar Health Research and Development Expense (Annual): 18.60M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.60M |
| December 31, 2022 | 17.65M |
| December 31, 2021 | 15.08M |
| December 31, 2020 | 6.413M |
| December 31, 2019 | 5.82M |
| Date | Value |
|---|---|
| December 31, 2018 | 5.155M |
| December 31, 2017 | 4.270M |
| December 31, 2016 | 7.207M |
| December 31, 2015 | 6.476M |
| December 31, 2014 | 4.220M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
5.82M
Minimum
2019
18.60M
Maximum
2023
12.71M
Average
15.08M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.31M |
| Alaunos Therapeutics Inc | 16.28M |
| Oragenics Inc | 15.49M |
| Cocrystal Pharma Inc | 15.17M |
| Chimerix Inc | 68.79M |